Femostop
Payments companies reported to CMS as associated with Femostop. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Femostop, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Femostop
These are the largest totals companies reported as associated with Femostop. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Bryan Fisher | Hendersonville, TN | Vascular Surgery | $9,775.00 |
| Mehran Massumi | Houston, TX | Interventional Cardiology | $2,500.00 |
| Hemal Nayak | San Antonio, TX | Clinical Cardiac Electrophysiology | $148.49 |
| Peter Farrugia | Colts Neck, NJ | Cardiovascular Disease | $87.19 |
| David Katz | Atlantic City, NJ | Surgical | $41.70 |
| Wisam Martini | Dyer, IN | Interventional Cardiology | $39.64 |
| Carlos Alves | Seattle, WA | Clinical Cardiac Electrophysiology | $34.56 |
| David Spinosa | Fairfax, VA | Diagnostic Radiology | $32.01 |
| Michael Tedla | Bradenton, FL | Cardiovascular Disease | $30.87 |
| Kara Turpin | Rock Hill, SC | Clinical Cardiac Electrophysiology | $28.41 |
Prescribed Femostop?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.